IRS1 and Insulin resistance: The activated JNK causes insulin resistance in obesity and possibly in diabesity in four ways: inhibition of IRS-1 phosphorylation directly, the inhibition of PPARα-FGF21 axis hormones, induction of cytokines and inflammation, and enhanced metabolic and adipogenesis efficiency [153, 154].